Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO.sub.2) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate.

Novel tools and techniques are provided for implementing intelligent assistance (“IA”) ecosystem. In various embodiments, a computing system might receive device data associated with a device(s) configured to perform a task(s), might receive sensor data associated with sensors configured to monitor at least one of biometric, biological, genetic, cellular, or procedure-related data of a subject, and might receive imaging data associated with an imaging device(s) configured to generate images of a portion(s) of the subject. The computing system might analyze the received device data, sensor data, and imaging data (collectively “received data”), might map two or more of the received data to a 3D or 4D representation of the portion(s) of the subject based on the analysis, might generate and present (using a user experience (“UX”) device) one or more extended reality (“XR”) images or experiences based on the mapping.

A method of creating a shunt between a right atrium and a left atrium of a mammalian heart including puncturing an atrial septum between the right atrium and the left atrium to create a shunt. An ablation device having balloon is advanced at least partially through the shunt. The balloon is inflated and configured to thermally isolate the atrial septum from blood within the left atrium and the right atrium. Ablation energy is delivered to ablate the atrial septum.

A catheter system (100) for treating one or more treatment sites (106) within or adjacent to the heart valve (108) includes an energy source (124), a plurality of energy guides (122A), and a balloon assembly (104). The energy source (124) generates energy. The plurality of energy guides (122A) are configured to receive energy from the energy source (124). The balloon assembly (104) includes a plurality of balloons (104A) that are each positionable substantially adjacent to one or more treatment site(s) (106). Each of the plurality of balloons (104A) has a balloon wall (130) that defines a balloon interior (146). Each of the plurality of balloons (104A) is configured to retain a balloon fluid (132) within the balloon interior (146). A portion of at least one of the plurality of energy guides (122A) that receive the energy from the energy source (124) is positioned within the balloon interior (146) of each of the plurality of balloons (104A) so that plasma is formed in the balloon fluid (132) within the balloon interior (146).

Devices, systems, and methods for treating pulmonary conditions, such as COPD and asthma, by denervating bronchial tissue using cryoablation. In one embodiment, a device for bronchial denervation comprises: an elongate body having a distal portion and a proximal portion opposite the distal portion; a treatment element at the distal portion of the elongate body; and a first recording electrode located distal to the treatment element and a second recording electrode located proximal to the treatment element, the first and second recording electrodes being configured to record electromyograms. In one embodiment, the device includes a fluid delivery element that is within the treatment element and that has a plurality of orifices aligned with an equatorial portion of the treatment element.

Provided herein are methods, devices, compositions, and kits for monitoring neuromodulation efficacy based on changes in the level or activity of one or more target biomarkers. One aspect includes a comparison of baseline and post-modulation levels of one or more biomarkers in bodily fluid that have each been collected from a human subject at a relevant time, and that may be used to assess the neuromodulation efficacy. The post-neuromodulation levels for the one or more biomarkers may be collected from the human subject within about 5 minutes to about 14 days post-neuromodulation.

A balloon-type electrode catheter includes a catheter shaft, a balloon provided at a part including a distal end of the catheter shaft and being inflatable with a fluid, and an electrode. The balloon includes a through hole discharging a fluid in the balloon to an outside of the balloon, a distal end large diameter portion, a proximal end large diameter portion, a small diameter portion positioned between the two large diameter portions and being smaller in diameter than the two large diameter portions, a distal end inclined portion connecting the distal end large diameter portion and the small diameter portion, and a proximal end inclined portion connecting the proximal end large diameter portion and the small diameter portion. The electrode is exposed at at least the small diameter portion. The through hole is disposed in at least one of the distal end inclined portion or the proximal end inclined portion.

A balloon-type electrode catheter includes a catheter shaft including an outer shaft and an inner shaft, a balloon provided at a part including a distal end of the catheter shaft, and an electrode. The balloon includes an outer joining portion an inner joining portion, a distal end large diameter portion, a proximal end large diameter portion, a small diameter portion positioned between the two large diameter portions and being smaller in diameter than the two large diameter portions, a distal end inclined portion connecting the distal end large diameter portion and the small diameter portion, and a proximal end inclined portion connecting the proximal end large diameter portion and the small diameter portion. The electrode is exposed at at least the small diameter portion.

An ablation catheter including an elongate shaft, an inflatable balloon positioned at a distal region of the elongate shaft, a first ablation electrode disposed outside of and carried by an outer surface of the inflatable balloon, a first ultrasound transducer disposed outside of the inflatable balloon, and a flexible circuit. The flexible circuit includes a first conductor and a second conductor and is disposed outside of and carried by the outer surface of the inflatable balloon. The first conductor is in electrical communication with the first ablation electrode, and the second conductor in electrical communication with the first ultrasound transducer.

Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO.sub.2) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate.